DST / AIDS and Viral Hepatitis Program of Macaé
Macaé, Rio de Janeiro, Brazil
NCT Number: NCT03485248
Administration of antiretroviral therapy has brought benefits for infective human immunodeficiency virus-1 (HIV-1)-patients, reducing the number of AIDS-related morbidity and mortality. However, it is responsible for intensifying complications triggered by the chronic inflammatory state associated with virus infection, such as cardiovascular diseases. The current study evaluated effects of single dose (140mL) of Beetroot Juice (BJ) on macro and microvascular endothelial function in HIV-1-patients undergoing antiretroviral terapy, once BJ was shown to be effective in improving these physiological parameters in uninfected individuals.
Looking for future studies?
Notify Me18 year–59 year
All sexes
Interventional
Not applicable
Macaé, Rio de Janeiro, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
140ml of Beetroot Juice containing on avarege 9 mmol of nitrate
140ml of Beetroot Juice (nitrate free)
Time frame: Baseline and approximately after 150 minutes of beetroot juice consumption
Changes in skeletal muscle oxygenation in response to exercise will be evaluated by using a near-infrared spectroscopy device.
Time frame: Baseline and approximately after 150 minutes of beetroot juice consumption
The brachial artery flow-mediated dilation will be evaluated by using an ultrasound device.
Time frame: Baseline and approximately 30, 90, and 150 minutes after beetroot juice consumption
Analysis of nitrate in urine will be performed by using high-performance liquid chromatography system.
Universidade Federal do Rio de Janeiro
Other
Effect of Ingestion of Beet Juice on Endothelial Function, Arterial Stiffness and Muscle Oxygenation Parameters in People Living With HIV / AIDS Using Antiretroviral Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05609513
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kampala, Uganda
View Trial DetailsNCT06739915
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Soweto, Gauteng, South Africa
View Trial DetailsNCT04446611
Acquired Immunodeficiency Syndrome, Antenatal Care
East London, Eastern Cape, South Africa
View Trial DetailsNCT05121064
Acquired Immunodeficiency Syndrome, Alcohol-Related Disorders
Lusaka, Zambia
View Trial Details